These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 8195509)

  • 1. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
    Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oversensing during bradycardia pacing in two types of implantable cardioverter-defibrillator systems.
    Mann DE; Damle RS; Kelly PA; Landers M; Otto L; Reiter MJ
    Am Heart J; 1998 Oct; 136(4 Pt 1):658-63. PubMed ID: 9778069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillator: Ventritex Cadence.
    Fain ES; Winkle RA
    J Cardiovasc Electrophysiol; 1993 Apr; 4(2):211-23. PubMed ID: 8269293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
    Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
    J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undersensing during ventricular tachyarrhythmias in a third-generation implantable cardioverter defibrillator: diagnosis using stored electrograms and correction with programming.
    Mann DE; Kelly PA; Damle RS; Reiter MJ
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1525-30. PubMed ID: 7991424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique sensing errors in third-generation implantable cardioverter-defibrillators.
    Callans DJ; Hook BG; Kleiman RB; Mitra RL; Flores BT; Marchlinski FE
    J Am Coll Cardiol; 1993 Oct; 22(4):1135-40. PubMed ID: 8409053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with three different third-generation cardioverter-defibrillators in patients with coronary artery disease or cardiomyopathy.
    Porterfield JG; Porterfield LM; Smith BA; Bray L
    Am J Cardiol; 1993 Aug; 72(3):301-4. PubMed ID: 8342508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices.
    Hurwitz JL; Hook BG; Flores BT; Marchlinski FE
    J Am Coll Cardiol; 1993 Mar; 21(4):895-900. PubMed ID: 8450157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillator therapy in the absence of significant symptoms. Rhythm diagnosis and management aided by stored electrogram analysis.
    Hook BG; Callans DJ; Kleiman RB; Flores BT; Marchlinski FE
    Circulation; 1993 Jun; 87(6):1897-906. PubMed ID: 8504502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The concurrent implantation of a last-generation automatic defibrillator and a 2-chamber pacemaker].
    Cesario AS; Palermo P; Baragli D; Amici E; Biancalana G; Gambelli G; Neri R
    G Ital Cardiol; 1998 Aug; 28(8):878-86. PubMed ID: 9773313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bradycardia pacing caused by far-field atrial sensing in a third-generation cardioverter defibrillator with an automatic gain feature.
    Curwin JH; Roelke M; Ruskin JN
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):124-6. PubMed ID: 8848369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs.
    Rankin AC; Zaim S; Powell A; Zaim B; Brooks R; McGovern BA; Garan H; Ruskin JN
    Br Heart J; 1993 Jul; 70(1):61-9. PubMed ID: 8038001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate implantable cardioverter defibrillator shocks secondary to sensing lead failure: utility of stored electrograms.
    Almeida HF; Buckingham TA
    Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 1):407-11. PubMed ID: 7681191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture.
    Gunderson BD; Swerdlow CD; Wilcox JM; Hayman JE; Ousdigian KT; Ellenbogen KA
    Heart Rhythm; 2010 May; 7(5):626-33. PubMed ID: 20184977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.